The Board of Directors of , at its meeting held today have approved the unaudited Standalone financial results of the company for the period ended September 30, 2021.
For the quarter ended September 30, 2021(Q2 FY2022), the company's total income was ₹ 151.0309 crore, against ₹208.7296 crore in the corresponding quarter of the previous year (YoY) and ₹186.3683 crore in previous quarter (QoQ).
For the quarter ended September 30, 2021(Q2 FY2022), the company's net profit / (loss) was ₹17.2515 crore, against ₹20.1167 crore in the corresponding quarter of the previous year (YoY) and ₹19.2171 crore in previous quarter (QoQ).
For the quarter ended September 30, 2021(Q2 FY2022), the company's Earnings Per Share (EPS) was ₹6.25, against ₹7.29 in the corresponding quarter of the previous year (YoY) and ₹6.96 in previous quarter (QoQ).
Total Income | ₹ 151.0309 crs | ₹186.3683 crs | -18.96% | ₹208.7296 crs | -27.64% |
Net Profit | ₹17.2515 crs | ₹19.2171 crs | -10.23% | ₹20.1167 crs | -14.24 % |
EPS | ₹6.25 | ₹6.96 | -10.20% | ₹7.29 | -14.27% |
For the 6 Months period ended September 30, 2021(Half Year Ended FY 2022), the company's total income was ₹337.3992 crore, against ₹349.4645 crore in the previous year (YoY) (Half Year Ended FY 2021).
The net profit / (loss) was at ₹36.4686 crore for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), compared to ₹35.4083 crore in the previous year (YoY) (Half Year Ended FY 2021).
The Earnings Per Share stood at ₹13.21 for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), against ₹12.83 in the previous year (YoY) (Half Year Ended FY 2021).
Total Income | ₹337.3992 crs | ₹349.4645 crs | -3.45% |
Net Profit | ₹36.4686 crs | ₹35.4083 crs | 2.99% |
EPS | ₹13.21 | ₹12.83 | 2.96% |
Source : Equity Bulls
Keywords
BajajHealthcare
Q2FY22
H1FY22
ResultUpdate